跳至主要内容
临床试验/NCT01477307
NCT01477307已完成不适用

Effect of Dietary Intervention on Intestinal Microbiota in Patients With Non-alcoholic Fatty Liver Disease

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
abundance of fecal abundance of fecal Bacteroidetes

研究概览

简要总结

In patients with NAFLD/NASH, changes in liver lipid composition and function tests following a short dietary intervention are associated with changes in gut microbiota

详细描述

Study Hypothesis: In patients with NAFLD/NASH, changes in liver lipid composition and function tests following a short dietary intervention are associated with changes in gut microbiota

Study period:

  • Study duration for the participant: 7-10 weeks (1-4 weeks screening period, 3 weeks of intervention + 3 weeks of follow-up)
  • Expected study completion date: 30.04.2012 Study type: Single arm before-after study

Number of patients:

20 subjects with obesity and NAFLD / NASH

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Obesity defined as BMI>30 Abnormal liver function tests defined as ALT > 1.5 times the upper limit of normal NAFLD present at liver biopsy Age > 18 years, < 60 years

排除标准

  • Inability or unwillingness to give consent Bulimia Other known cause of chronic liver disease, including hepatitis B or C, iron overload, Use of substances known to alter intestinal permeability, including alcohol and NSAIDs

结局指标

主要结局

abundance of fecal abundance of fecal Bacteroidetes

时间窗: thrice, at inclusion, day 21 and day 42

Bacterial cells/g caecal content

次要结局

  • body composition(thrice, at inclusion, day 21 and day 42)
  • Breath test pullulation(twice, at inclusion and day 21)
  • serum LPS(twice, at inclusion and day 21)
  • intestinal permeability(twice, at inclusion and day 21)
  • liver fat content(twice, at inclusion and day 21)
  • liver function tests(four times, at screening, inclusion, day 21 and day 42)
  • CRP(thrice, at screening, inclusion and day 21)
  • serum cytokines(twice, at inclusion and day 21)
  • liver lipid composition (biopsy)(once, at screening)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Claude Pichard

Head, Clinical Nutrition

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验

Dietary Intervention and Intestinal Microbiota in... | 临床试验